Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has announced that Van Lanschot Kempen Investment Management NV has altered its voting rights holdings, crossing a threshold on June 7, 2024, which resulted in a decrease from 8.9111% to 7.76307% of total voting rights. This significant change was officially notified to the company on June 11, 2024. The adjustment reflects a change in share ownership stake by the Amsterdam-based investment firm in the UK pharmaceutical company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
